Geftiwel 250mg Tablet

Introduction

Geftiwel is a prescription medication that contains the active ingredient Gefitinib. It is available under the brand name Geftiwel. This medication is primarily used in the treatment of certain types of lung cancer.

Uses

Geftiwel is prescribed for the treatment of non-small cell lung cancer (NSCLC) that has certain specific genetic mutations. It is used in patients who have not responded to other chemotherapy treatments or have experienced disease progression after treatment.

Dosage and Administration

The dosage of Geftiwel may vary based on individual factors such as the patient’s weight, overall health, and response to treatment. Follow the instructions provided by your healthcare professional. Typically, the recommended dose is 250 mg taken orally once daily, with or without food. The tablet should be swallowed whole with a glass of water.

Mechanism of Action

Gefitinib, the active ingredient in Geftiwel, belongs to a class of medications known as tyrosine kinase inhibitors. It works by blocking the action of specific proteins in cancer cells, thereby inhibiting their growth and division. This helps to slow down the progression of the cancer.

Side Effects

Common side effects may include diarrhea, skin rash, acne, nausea, vomiting, loss of appetite, and fatigue. These side effects are usually mild and manageable. However, if you experience any severe or persistent side effects, such as difficulty breathing, chest pain, or severe skin reactions, seek medical attention immediately.

Drug Interactions

Geftiwel may interact with other medications, including certain antibiotics, antifungal drugs, and medications that affect liver enzymes. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. They can assess the potential interactions and adjust your treatment plan if necessary.

Precautions

Before starting treatment with Geftiwel, inform your healthcare professional about any existing medical conditions, including liver problems or lung disease. This medication may not be suitable for everyone, and your healthcare professional will assess the risks and benefits before prescribing it. Geftiwel is not recommended for use during pregnancy or breastfeeding.

Storage

Geftiwel should be stored at room temperature, away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Geftiwel exactly as prescribed by your healthcare professional.
• If you miss a dose, take it as soon as you remember unless it is close to the time for your next dose. Do not double the dose to make up for the missed one.
• attend regular follow-up appointments with your healthcare professional to monitor your response to the medication and manage any side effects.
• Inform your healthcare professional if you experience any new or worsening symptoms while taking Geftiwel.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Gefitinib 250 mg film-coated tablets (Health Professionals SmPC) Available at:
• Gefitinib (Drugs.com) [Accessed 0 Jun. 2024] (online) Available at:
• gefitinib 250 mg tablet antineoplastic – protein-tyrosine kinase inhibitors (RX) [Accessed 20 Jun. 2024] (online) Available at:
• Gefitinib (MedlinePlus) [Accessed 16 Jun. 2024] (online) Available at:
• Sun C, Gao W, Liu J, Cheng H, Hao J. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer. Respir Res. 2020 Aug 10;21(1):210. doi: 10.1186/s12931-020-01477-y. [Accessed 21 Jun. 2024] Available at: